Stephen Gaeta
Clinical Cardiac Electrophysiology · Fairfax, VANPI 1265731491
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 70.4% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $47,973, 7.1 times the $6,745 reported in 2019. Among clinical cardiac electrophysiology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $341.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$60K
- Biosense Webster, Inc.$17K
- Abbott$4K
- Boston Scientific$2K
- Medical Device Business Services, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$190
- plus $700 from 8 others
Across 2 payments — averaging $43,475 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$87K
What the payments were for
- Consulting fees$8,68810%
- Speaking & faculty fees$47,32056%
- Travel & lodging$18,76422%
- Food & beverage$10,06112%
- Education$1340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 127 | $59,839 |
| Biosense Webster, Inc. | 44 | $16,918 |
| Abbott | 41 | $3,885 |
| Boston Scientific | 18 | $2,359 |
| Medical Device Business Services, Inc. | 4 | $1,075 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $190 |
| Acutus Medical, Inc. | 1 | $184 |
| Atricure, Inc. | 1 | $163 |
| Impulse Dynamics (USA) Inc. | 2 | $126 |
| Cardiva Medical, Inc. | 1 | $119 |
| Kestra Medical Technology Services, Inc. | 2 | $53 |
| Johnson & Johnson | 1 | $24 |
| Pfizer | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$10,593
- Micra$3,925
- AVEIR$1,907
- GENERAL - THERAPIES$1,634
- Carto 3 System$1,219
- EVERA MRI XT DR SURESCAN$1,074
- AFFERA MAPPING SYSTEM$691
- SelectSecure$645
- Carto Smarttouch$338
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$274
- ENSITE$222
- OPTIMIZER$206
- Claria MRI$201
- LINQ II$164
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$163
- AGILIS$159
- AZURE XT DR MRI SURESCAN$147
- Vascular Closure Device$119
- COBALT DR MRI SURESCAN$116
- Confidense$109
How this compares
$84,966 in reported general payments places this provider in the 90th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 135 | $182,503 |
| XareltoRivaroxaban | 23 | $23,626 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 12 | $3,637 |
| Flecainide Acetate | 22 | $1,142 |
| Amiodarone Hcl | 45 | $949 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $700 |
| Metoprolol Succinate | 36 | $485 |
| Famotidine | 45 | $320 |
| Metoprolol Tartrate | 19 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $182,503135 claims |
| Johnson & JohnsonXarelto | $24 | $23,62623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Fairfax
- Brett AtwaterFairfax$319K
- Elizabeth HeldFairfax$84K
- Zachary HollisFairfax$23K
- Marc WishFairfax$22K
- David StrouseFairfax$18K
- Sarfraz DurraniFairfax$13K
- Kenneth EllenbogenRichmond$360K
- Oliver MonfrediCharlottesville$231K
- Peem LorvidhayaFredericksburg$230K
- Erich KiehlNewport News$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.